{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:24:48Z","timestamp":1790288688614,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bcp.2019.06.018","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T18:46:06Z","timestamp":1561056366000},"page":"82-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["2,5-Dimethylcelecoxib prevents isoprenaline-induced cardiomyocyte hypertrophy and cardiac fibroblast activation by inhibiting Akt-mediated GSK-3 phosphorylation"],"prefix":"10.1016","volume":"168","author":[{"given":"Shoji","family":"Morishige","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumi","family":"Takahashi-Yanaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Ishikane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Arioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunobu","family":"Igawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Kuroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Tomooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shiose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Sasaguri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2019.06.018_b0005","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/CIRCULATIONAHA.114.008788","article-title":"Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling","volume":"131","author":"Frieler","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2019.06.018_b0010","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.7150\/thno.22878","article-title":"MicroRNA-378 suppresses myocardial fibrosis through a paracrine mechanism at the early stage of cardiac hypertrophy following mechanicalstress","volume":"8","author":"Yuan","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2019.06.018_b0015","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI70577","article-title":"Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy","volume":"124","author":"Bang","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2019.06.018_b0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/hr.2016.122","article-title":"2,5-Dimethylcelecoxib prevents pressure-induced left ventricular remodeling through GSK-3 activation","volume":"40","author":"Fujita","year":"2017","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bcp.2019.06.018_b0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.111.179325","article-title":"Celecoxib and 2,5-dimethyl-celecoxib prevent cardiac remodeling inhibiting Akt-mediated signal transduction in an inherited dilated cardiomyopathy mouse model","volume":"338","author":"Fan","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2019.06.018_b0030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1172\/JCI24178","article-title":"Protein kinase cascades in the regulation of cardiac hypertrophy","volume":"115","author":"Dorn","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2019.06.018_b0035","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1161\/CIRCRESAHA.116.303613","article-title":"The GSK-3 family as therapeutic target for myocardial diseases","volume":"116","author":"Lal","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2019.06.018_b0040","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/01.RES.0000018952.70505.F1","article-title":"Glycogen synthase kinase-3\u03b2 \u2013 a novel regulator of cardiac hypertrophy and development","volume":"90","author":"Hardt","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2019.06.018_b0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.yjmcc.2017.07.011","article-title":"Entanglement of GSK-3\u03b2, \u03b2-catenin and TGF-\u03b21 signaling network to regulate myocardial fibrosis","volume":"110","author":"Guo","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bcp.2019.06.018_b0050","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1073\/pnas.231619298","article-title":"Activated glycogen synthase-3\u03b2 suppresses cardiac hypertrophy in vivo","volume":"99","author":"Antos","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bcp.2019.06.018_b0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1083\/jcb.151.1.117","article-title":"Glycogen synthase kinase-3\u03b2 is a negative regulator of cardiomyocyte hypertrophy","volume":"151","author":"Haq","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2019.06.018_b0060","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/cvr\/cvq061","article-title":"Constitutive glycogen synthase kinase-3\u03b1\/\u03b2 activity protects against chronic \u03b2-adrenergic remodelling of the heart","volume":"87","author":"Webb","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2019.06.018_b0065","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1158\/0008-5472.CAN-03-2396","article-title":"3-phosphoinositide-dependent protein kinase-1\/Akt signaling represents a major cyclooxygenase-2-independent target for celecoxib in prostate cancer cells","volume":"64","author":"Kulp","year":"2004","journal-title":"Can. Res."},{"key":"10.1016\/j.bcp.2019.06.018_b0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1517\/13543784.17.2.197","article-title":"Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs","volume":"17","author":"Schonthal","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bcp.2019.06.018_b0075","doi-asserted-by":"crossref","first-page":"571","DOI":"10.4161\/cbt.4.5.1699","article-title":"Dimethyl-celecoxib (DMC), a derivative of celecoxib that lacks cyclooxygenase-2-inhibitory function, potently mimics the anti-tumor effects of celecoxib on Burkitt's lymphoma in vitro and in vivo","volume":"4","author":"Kardosh","year":"2005","journal-title":"Can. Biol. Ther."},{"key":"10.1016\/j.bcp.2019.06.018_b0080","doi-asserted-by":"crossref","DOI":"10.1186\/s40360-017-0136-7","article-title":"Coenzyme Q10 prevents oxidative stress and fibrosis in isoprenaline induced cardiac remodeling in aged rats","volume":"18","author":"Ulla","year":"2017","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2019.06.018_b0085","doi-asserted-by":"crossref","unstructured":"W.L. Verloop, M.M, Beeftink, B.T. Santema, M.L. Bots, P.J. Blankestijn, M.J. Cramer, P.A. Doevendans, M. Voskuil, A systematic review concerning the relation between the sympathetic nervous system and heartfailure with preserved left ventricular ejection fraction, Plos One 10 (2015) e0117332.","DOI":"10.1371\/journal.pone.0117332"},{"key":"10.1016\/j.bcp.2019.06.018_b0090","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bcp.2018.04.012","article-title":"Angiotensin II promotes pulmonary metastasis of melanoma through the activation of adhesion molecules in vascular endothelial cells","volume":"154","author":"Ishikane","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2019.06.018_b0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.lfs.2017.10.034","article-title":"Sustained \u03b2-AR stimulation induces synthesis and secretion of growth factors in cardiac myocytes that affect on cardiac fibroblast activation","volume":"193","author":"Nuamnaichati","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2019.06.018_b0100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature11139","article-title":"Heart repair by reprogramming non-myocytes with cardiac transcription factors","volume":"485","author":"Song","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2019.06.018_b0105","first-page":"2369","article-title":"Stage-dependent benefits and risks of pimobendan in genetic dilated cardiomyopathy mice with progressive heart failure","volume":"172","author":"Nonaka","year":"2015","journal-title":"Biophys. J."},{"key":"10.1016\/j.bcp.2019.06.018_b0110","series-title":"Protein Electrophoresis Methods and Protocols","first-page":"205","author":"Kurien","year":"2012"},{"key":"10.1016\/j.bcp.2019.06.018_b0115","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1074\/jbc.M205768200","article-title":"Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3\u03b2 and degrades cyclin D1 in mammalian cells","volume":"278","author":"Takahashi-Yanaga","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2019.06.018_b0120","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1253\/circj.CJ-11-1114","article-title":"Effects of pitavastatin on pressure overload-induced heart failure in mice","volume":"76","author":"Kameda","year":"2012","journal-title":"Circ. J."},{"key":"10.1016\/j.bcp.2019.06.018_b0125","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.3892\/or.2017.5981","article-title":"Synergistic antitumor effects of the combined treatment with an HDAC6 inhibitor and a COX-2 inhibitor through activation of PTEN","volume":"38","author":"Zhang","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bcp.2019.06.018_b0130","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbrc.2015.03.008","article-title":"Activating PTEN by COX-2 inhibitors antagonizes radiation-induced AKT activation contributing to radiosensitization","volume":"460","author":"Meng","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2019.06.018_b0135","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.18632\/oncotarget.1745","article-title":"Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN","volume":"5","author":"Chu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2019.06.018_b0140","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.yjmcc.2017.11.018","article-title":"DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17\/ACE2 and GSK-3\u03b2\/\u03b2-catenin pathways","volume":"114","author":"Zhai","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bcp.2019.06.018_b0145","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCRESAHA.114.302022","article-title":"Mammalian target of rapamycin signaling in cardiac physiology and disease","volume":"114","author":"Sciarretta","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2019.06.018_b0150","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/jpet.115.225011","article-title":"2,5-Dimethyl-celecoxib inhibits cell cycle progression and induces apoptosis in human leukemia cells","volume":"355","author":"Sobolewski","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2019.06.018_b0155","first-page":"108","article-title":"Celecoxib and 2,5-dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt\/\u03b2-catenin signaling pathway","volume":"108","author":"Egashira","year":"2017","journal-title":"Can. Sci."},{"key":"10.1016\/j.bcp.2019.06.018_b0160","doi-asserted-by":"crossref","first-page":"571","DOI":"10.4161\/cbt.4.5.1699","article-title":"Dimethyl-celecoxib (DMC), a derivative of celecoxib that lacks cyclooxygenase-2-inhibitory function, potently mimics the anti-tumor effects of celecoxib on Burkitt's lymphoma in vitro and in vivo","volume":"4","author":"Kardosh","year":"2005","journal-title":"Can. Biol. Ther."},{"key":"10.1016\/j.bcp.2019.06.018_b0165","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cellsig.2007.10.018","article-title":"GSK-3\u03b2 regulates cyclin D1 expression: a new target for chemotherapy","volume":"20","author":"Takahashi-Yanaga","year":"2008","journal-title":"Cell Signal"},{"key":"10.1016\/j.bcp.2019.06.018_b0170","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.RES.0000013290.12884.A3","article-title":"Matrix metalloproteinases: regulation and dysregulation in the failing heart","volume":"90","author":"Spinale","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2019.06.018_b0175","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0008-6363(00)00030-4","article-title":"Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis","volume":"46","author":"MacKenna","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2019.06.018_b0180","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCRESAHA.110.231225","article-title":"G protein-dependent and G protein-independent signaling pathways and their impact on cardiac function","volume":"109","author":"Tilley","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2019.06.018_b0185","doi-asserted-by":"crossref","first-page":"32430","DOI":"10.1038\/srep32430","article-title":"Proliferation in cardiac fibroblasts induced by \u03b21-adrenoceptor autoantibody and the underlying mechanisms","volume":"6","author":"Lv","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2019.06.018_b0190","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.RES.0000102042.83024.CA","article-title":"What is the role of beta-adrenergic signaling in heart failure?","volume":"93","author":"Lohse","year":"2003","journal-title":"Cir. Res."},{"key":"10.1016\/j.bcp.2019.06.018_b0195","doi-asserted-by":"crossref","first-page":"H385","DOI":"10.1152\/ajpheart.01318.2006","article-title":"A novel signaling pathway for \u03b2-adrenergic receptor-mediated activation of phosphoinositide 3-kinase in H9c2 cardiomyocytes","volume":"293","author":"Yano","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.bcp.2019.06.018_b0200","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10741-013-9417-4","article-title":"A pathway and network review on \u03b2-adrenoceptor signaling and \u03b2-blockers in cardiac remodeling","volume":"19","author":"Yang","year":"2014","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.bcp.2019.06.018_b0205","doi-asserted-by":"crossref","first-page":"147","DOI":"10.7888\/juoeh.40.147","article-title":"Roles of glycogen synthase kinase-3 (GSK-3) in cardiac development and heart disease","volume":"40","author":"Takahashi-Yanaga","year":"2018","journal-title":"J. UOEH"},{"key":"10.1016\/j.bcp.2019.06.018_b0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1755-1536-5-15","article-title":"Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease","volume":"5","author":"Fan","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.bcp.2019.06.018_b0215","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/hy0202.103481","article-title":"Fibrosis, matrix metalloproteinases and inflammation in the heart of DOCA-salt hypertensive rats: role of ETA receptors","volume":"39","author":"Amiri","year":"2002","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bcp.2019.06.018_b0220","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0968-0004(00)89005-2","article-title":"D-type cyclins","volume":"20","author":"Sherr","year":"1995","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bcp.2019.06.018_b0225","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/cvr\/cvx146","article-title":"Fibroblasts and the extracellular matrix in right ventricular disease","volume":"113","author":"Frangogiannis","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2019.06.018_b0230","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.yjmcc.2005.12.005","article-title":"Noncanonical cAMP pathway and p38 MAPK mediate \u03b22-adrenergic receptor-induced IL-6 production in neonatal mouse cardiac fibroblasts","volume":"40","author":"Yin","year":"2006","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.bcp.2019.06.018_b0235","doi-asserted-by":"crossref","first-page":"32116","DOI":"10.1074\/jbc.M204895200","article-title":"\u03b2-Adrenergic receptor-mediated DNA synthesis in cardiac fibroblasts is dependent on transactivation of the epidermal growth factor receptor and subsequent activation of extracellular signal-regulated kinases","volume":"277","author":"Kim","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2019.06.018_b0240","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.1074\/jbc.273.22.13375","article-title":"The tumor suppressor, PTEN\/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate","volume":"273","author":"Maehama","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2019.06.018_b0245","doi-asserted-by":"crossref","first-page":"9847","DOI":"10.1074\/jbc.M109.091637","article-title":"Functional interaction of phosphatase and tensin homologue (PTEN) with the E3 ligase NEDD4-1 during neuronal response to zinc","volume":"285","author":"Kwak","year":"2010","journal-title":"J. Biol. Chem."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219302370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219302370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:05:39Z","timestamp":1757768739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219302370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":49,"alternative-id":["S0006295219302370"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.06.018","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2,5-Dimethylcelecoxib prevents isoprenaline-induced cardiomyocyte hypertrophy and cardiac fibroblast activation by inhibiting Akt-mediated GSK-3 phosphorylation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.06.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}